NASDAQ-GM · traded in Congress
Veracyte, VCYT
$24.27 +0.11 (+0.46%) Nov 9, 2026 4:27 AM ET
Market value$2.0B
P/E ratio-
Analyst target$54.50
52-week range-
Avg volume1,319,676
Dividend yieldN/A
Chart
Analyst ratings
- 10 buy
- 3 hold
- 0 sell
Low target$35.00
Average target$51.10
High target$66.00
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $152M | $107M | $32M | 20.8% | |
| $150M | $109M | $25M | 17.0% | |
| $139M | $101M | $29M | 20.6% | |
| $141M | $102M | $41M | 29.3% |
Congress trades in VCYT
Members of Congress disclosed 1 transaction in VCYT in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 03/03/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 4/7/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
